ID23951A - Pengobatan diabetes dengan rosiglitazon dan insulin - Google Patents

Pengobatan diabetes dengan rosiglitazon dan insulin

Info

Publication number
ID23951A
ID23951A IDW991627A ID991627A ID23951A ID 23951 A ID23951 A ID 23951A ID W991627 A IDW991627 A ID W991627A ID 991627 A ID991627 A ID 991627A ID 23951 A ID23951 A ID 23951A
Authority
ID
Indonesia
Prior art keywords
rosiglitazone
insulin
diabetes
treatment
Prior art date
Application number
IDW991627A
Other languages
English (en)
Indonesian (id)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23951A publication Critical patent/ID23951A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW991627A 1997-06-18 1998-06-15 Pengobatan diabetes dengan rosiglitazon dan insulin ID23951A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ID23951A true ID23951A (id) 2000-06-08

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991627A ID23951A (id) 1997-06-18 1998-06-15 Pengobatan diabetes dengan rosiglitazon dan insulin

Country Status (30)

Country Link
EP (1) EP0999837A1 (OSRAM)
JP (1) JP2002504138A (OSRAM)
KR (1) KR20010013843A (OSRAM)
CN (1) CN1133431C (OSRAM)
AP (1) AP1287A (OSRAM)
AR (2) AR012997A1 (OSRAM)
AU (1) AU8216398A (OSRAM)
BG (1) BG104059A (OSRAM)
BR (1) BR9810444A (OSRAM)
CA (1) CA2294141A1 (OSRAM)
CO (1) CO4940454A1 (OSRAM)
DZ (1) DZ2521A1 (OSRAM)
EA (1) EA004800B1 (OSRAM)
GB (1) GB9712866D0 (OSRAM)
HU (1) HUP0003260A3 (OSRAM)
ID (1) ID23951A (OSRAM)
IL (1) IL133143A0 (OSRAM)
IN (1) IN189723B (OSRAM)
MA (1) MA26511A1 (OSRAM)
NO (1) NO996265L (OSRAM)
OA (1) OA11517A (OSRAM)
PE (1) PE104499A1 (OSRAM)
PL (1) PL343123A1 (OSRAM)
SK (1) SK179399A3 (OSRAM)
TR (1) TR199903095T2 (OSRAM)
TW (1) TW587937B (OSRAM)
UA (1) UA70299C2 (OSRAM)
UY (1) UY25050A1 (OSRAM)
WO (1) WO1998057636A1 (OSRAM)
ZA (1) ZA985237B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
AU765498B2 (en) 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical
US6660716B1 (en) * 1999-06-21 2003-12-09 Eli Lilly And Company Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof
CA2369839A1 (en) * 1999-06-25 2001-01-04 Minimed, Inc. Compositions of insulin and insulin-related peptide for treating diabetes
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
WO2002100396A1 (en) * 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
ES2295692T3 (es) * 2002-11-08 2008-04-16 F. Hoffmann-La Roche Ag Nuevos derivados de 4-alcoxioxazol sustituido como agonistas de ppar.
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0719140T3 (da) * 1993-09-15 2008-03-03 Daiichi Sankyo Co Ltd Anvendelse af thiazolidindioner til forebyggelse eller forsinkelse af indtræden af NIDDM
CN1192683A (zh) * 1995-08-10 1998-09-09 沃尼尔·朗伯公司 减少非胰岛素依赖型糖尿病患者外源性胰岛素给药量的方法
DK0859608T3 (da) * 1995-09-18 2004-06-14 Ligand Pharm Inc Behandling af NIDDM med RXR-agonister

Also Published As

Publication number Publication date
GB9712866D0 (en) 1997-08-20
PE104499A1 (es) 2000-01-13
HUP0003260A3 (en) 2001-12-28
AU8216398A (en) 1999-01-04
CN1133431C (zh) 2004-01-07
DZ2521A1 (fr) 2003-02-08
TR199903095T2 (xx) 2000-08-21
AP1287A (en) 2004-06-26
ZA985237B (en) 2000-02-17
KR20010013843A (ko) 2001-02-26
HUP0003260A2 (hu) 2001-05-28
OA11517A (en) 2004-02-04
AP9901718A0 (en) 1999-12-31
EA200000042A1 (ru) 2000-08-28
MA26511A1 (fr) 2004-12-20
AR012997A1 (es) 2000-11-22
SK179399A3 (en) 2000-11-07
CN1260715A (zh) 2000-07-19
IL133143A0 (en) 2001-03-19
PL343123A1 (en) 2001-07-30
TW587937B (en) 2004-05-21
NO996265D0 (no) 1999-12-17
UY25050A1 (es) 2000-09-29
BR9810444A (pt) 2000-09-05
UA70299C2 (en) 2004-10-15
WO1998057636A1 (en) 1998-12-23
IN189723B (OSRAM) 2003-04-19
BG104059A (en) 2000-10-31
CO4940454A1 (es) 2000-07-24
NO996265L (no) 1999-12-17
EP0999837A1 (en) 2000-05-17
JP2002504138A (ja) 2002-02-05
CA2294141A1 (en) 1998-12-23
EA004800B1 (ru) 2004-08-26
AR015894A1 (es) 2001-05-30

Similar Documents

Publication Publication Date Title
ID23372A (id) Pengobatan diabetes dengan tiazolidindion dan metformin
EE9900328A (et) Tiasooli benseensulfoonamiidid ß3-agonistidena diabeedi ja rasvumuse ravis
ID24211A (id) Pengobatan penyakit gula dengan thiazolidindion, insulin sekretatagogue dan diguanida
NO996265L (no) Behandling av diabetes med rosiglitazon og insulin
FI953665L (fi) Bentsoksatsolyyli- ja bentsotiatsolyylioksatsolidinoneja
ID24065A (id) Pengobatan diabetes dengan tiozolidindinon dan sulfonilurea
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
NO20000229D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
HK1028198A (en) Treatment of diabetes with rosiglitazone and insulin
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
BR9605424A (pt) Seringa auto-destrutiva e auto-bloqueante
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea